Rutgers University Study of the Genetics of Blood Cancers

Part of paid clinical trials in Piscataway, New Jersey.

Sponsor
Rutgers, The State University of New Jersey
Study ID
NCT07714044
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Blood Cancer
  • Blood Cancers
  • Hematologic Cancer
  • Hematologic Malignancies
  • Hematologic Neoplasm
  • Hematologic Tumors
  • Leukemia
  • Lymphoma
  • Myeloma

Eligibility Criteria

Sex
ALL
Age
18 Years - 110 Years
Healthy Volunteers
Accepted

Study Details

The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.

Key Dates

First listed
Jul 20, 2026
Start date
Aug 31, 2026
Status verified
Jul 2026
Primary completion
Aug 31, 2029
Completion
Aug 31, 2029

Study Design

Enrollment
10,000 participants (estimated)

Arms

  • Arm: Cases
    Persons with blood cancer
  • Arm: Controls
    Persons who do not have blood cancer

Primary Outcome Measure

Genetic risk variants associated with blood cancer [ Time Frame: 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Rutgers UniversityPiscatawayNew Jersey08854
Tara Matise, PhD
[email protected]
848-445-3125
Tara Matise, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Piscataway, NJ

By condition
Leukemia (other)Multiple myeloma
By specialty
OncologyBlood cancer
By research site
Rutgers University· Piscataway, NJ

Related Studies